22 related articles for article (PubMed ID: 19186063)
1. Efficient automated syntheses of high specific activity 6-[18F]fluorodopamine using a diaryliodonium salt precursor.
Neumann KD; Qin L; VÄvere AL; Shen B; Miao Z; Chin FT; Shulkin BL; Snyder SE; DiMagno SG
J Labelled Comp Radiopharm; 2016 Jan; 59(1):30-4. PubMed ID: 26695865
[TBL] [Abstract][Full Text] [Related]
2. A simplified protocol for the automated production of 2-[
Bhuiyan M; Souris J; Kucharski A; Freifelder R; Mukherjee J; Chen CT
J Labelled Comp Radiopharm; 2024 Jan; 67(1):31-36. PubMed ID: 37927198
[TBL] [Abstract][Full Text] [Related]
3. High molar activity [
Soloviev D; Dzien P; Mackintosh A; Malviya G; Brown G; Lewis D
EJNMMI Radiopharm Chem; 2022 Dec; 7(1):32. PubMed ID: 36512196
[TBL] [Abstract][Full Text] [Related]
4. Highlighting the Versatility of the Tracerlab Synthesis Modules. Part 1: Fully Automated Production of [F]Labelled Radiopharmaceuticals using a Tracerlab FX(FN).
Shao X; Hoareau R; Hockley BG; Tluczek LJ; Henderson BD; Padgett HC; Scott PJ
J Labelled Comp Radiopharm; 2011 May; 54(6):292-307. PubMed ID: 21769163
[TBL] [Abstract][Full Text] [Related]
5. Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?
Colom M; Vidal B; Zimmer L
Front Mol Neurosci; 2019; 12():255. PubMed ID: 31680859
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of a promising fluorine-18 labelled radiopharmaceutical for in vivo imaging of fatty acid amide hydrolase.
Sadovski O; Hicks JW; Parkes J; Raymond R; Nobrega J; Houle S; Cipriano M; Fowler CJ; Vasdev N; Wilson AA
Bioorg Med Chem; 2013 Jul; 21(14):4351-7. PubMed ID: 23712084
[TBL] [Abstract][Full Text] [Related]
7. The automated radiosynthesis of [18F]FP-TZTP.
Kiesewetter DO; Vuong BK; Channing MA
Nucl Med Biol; 2003 Jan; 30(1):73-7. PubMed ID: 12493545
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of [18F]FP-TZTP binding by loading doses of muscarinic agonists P-TZTP or FP-TZTP in vivo is not due to agonist-induced reduction in cerebral blood flow.
Shimoji K; Esaki T; Itoh Y; Ravasi L; Cook M; Jehle J; Jagoda EM; Kiesewetter DO; Schmidt K; Sokoloff L; Eckelman WC
Synapse; 2003 Nov; 50(2):151-63. PubMed ID: 12923818
[TBL] [Abstract][Full Text] [Related]
9. Regional brain uptake of the muscarinic ligand, [18F]FP-TZTP, is greatly decreased in M2 receptor knockout mice but not in M1, M3 and M4 receptor knockout mice.
Jagoda EM; Kiesewetter DO; Shimoji K; Ravasi L; Yamada M; Gomeza J; Wess J; Eckelman WC
Neuropharmacology; 2003 Apr; 44(5):653-61. PubMed ID: 12668051
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the pharmacokinetics of different analogs of 11C-labeled TZTP for imaging muscarinic M2 receptors with PET.
Reid AE; Ding YS; Eckelman WC; Logan J; Alexoff D; Shea C; Xu Y; Fowler JS
Nucl Med Biol; 2008 Apr; 35(3):287-98. PubMed ID: 18355684
[TBL] [Abstract][Full Text] [Related]
11. A concise radiosynthesis of the tau radiopharmaceutical, [(18) F]T807.
Shoup TM; Yokell DL; Rice PA; Jackson RN; Livni E; Johnson KA; Brady TJ; Vasdev N
J Labelled Comp Radiopharm; 2013 Dec; 56(14):736-40. PubMed ID: 24339014
[TBL] [Abstract][Full Text] [Related]
12. An improved radiosynthesis of the muscarinic M2 radiopharmaceutical, [18F]FP-TZTP.
van Oosten EM; Wilson AA; Stephenson KA; Mamo DC; Pollock BG; Mulsant BH; Yudin AK; Houle S; Vasdev N
Appl Radiat Isot; 2009 Apr; 67(4):611-6. PubMed ID: 19186063
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
